Industry News
Diabetes project sets new trend for NHMRC
The National Health and Medical Research Council (NHMRC) has come up with a new model for commercialising medical research. [ + ]
Give biotechs a break: tax study
Biotechs need better tax breaks, according to a new report. [ + ]
Sun helps launch medical 'holodeck'
The University of Calgary and Sun Microsystems have launched the Sun Centre of Excellence for Visual Genomics, a new kind of bioinformatics facility which uses 3D technology to view complex data of the human body. [ + ]
National Measurement Laboratory developments
The National Measurement Laboratory is seeking comment on a series of proposed new areas of activity. As part of this exercise, comment is being sought on industry interests in several areas listed below. [ + ]
Former PPL director Colman joins ES Cell
Embryonic stem cell researcher ES Cell International (ESI) has announced five senior management positions as it gears up for its development phase. [ + ]
Vics look overseas to fill top job
Offshore candidates are likely to be prime contenders for the Victorian Government's newly created position of director of biotechnology. [ + ]
Industry group has new Canberra presence
The new executive director of the Scientific Industry Association (SIA) says being based in Canberra will help the organisation to have a stronger voice. [ + ]
NZ will lose to Australia: bioentrepreneur
A prominent New Zealand entrepreneur has warned that financial institutions needed to take a punt on the emerging sector or risk losing business to Australia. [ + ]
Peptech seeking new CEO
Sydney biotech Peptech is on the hunt for a new CEO. [ + ]
BresaGen: stem cell debate won't affect our research
BresaGen has reassured investors its projects are not threatened by potential regulation of stem cell research in Australia. [ + ]
Panbio pulls back from dendrimer joint venture
A million-dollar collaboration between nano-drug company Starpharma and diagnostics specialist PanBio Ltd has come unstuck. [ + ]
Cryosite poised for listing
Cryosite, a Sydney-based biotechnology service company that stores frozen biological material, is going public. [ + ]
Melbourne to host international genetics congress
Bumper year, 2003 - it's the 50th anniversary of the Watson and Crick's now famous paper on the structure of the DNA molecule. [ + ]
Biota aims to reclaim position after flat half-year
Biota Holdings' much-hyped influenza drug, Relenza, failed to contribute revenue in an interim result that saw the company record a loss of $3.2 million. [ + ]
Europe to be left behind
Europe risks being left behind in the biotechnology sector unless it finds a way to address public fears about genetically modified organisms, a top European Union official has warned. [ + ]
